News

Where the latest HCV drug combos fit in
- Author:
- Bruce Jancin
Publish date: May 6, 2018
News

Drug-coated balloons: The future of hemodialysis access?
- Author:
- Bruce Jancin
Publish date: May 3, 2018
News

Cost-effectiveness battle: FFR vs. iFR in DEFINE-FLAIR trial
- Author:
- Bruce Jancin
Publish date: May 2, 2018
News

Treatment of HCV in special populations
- Author:
- Bruce Jancin
Publish date: May 2, 2018
News
Nebivolol looks like best beta-blocker for hypertension
- Author:
- Bruce Jancin
Publish date: May 1, 2018
News

Avoiding in-hospital acute kidney injury is a new imperative
- Author:
- Bruce Jancin
Publish date: April 29, 2018
News

Key to MGUS and myeloma may lie in Iceland
- Author:
- Bruce Jancin
Publish date: April 27, 2018
News

MI before age 50? Think familial hypercholesterolemia, substance abuse
- Author:
- Bruce Jancin
Publish date: April 26, 2018
News
Beware nonopiate meds with high street value
- Author:
- Bruce Jancin
Publish date: April 25, 2018
News

Hidradenitis suppurativa packs mighty QOL impact
- Author:
- Bruce Jancin
Publish date: April 25, 2018
News

Psoriasis duration reflects cardiovascular event risk
- Author:
- Bruce Jancin
Publish date: April 24, 2018
News

Is PASI 100 the new benchmark in psoriasis?
- Author:
- Bruce Jancin
Publish date: April 24, 2018
News

Keloids: Cutting is never enough
- Author:
- Bruce Jancin
Publish date: April 24, 2018
News

Statin-associated muscle symptoms? Rechallenge!
- Author:
- Bruce Jancin
Publish date: April 20, 2018
News

Apixaban prevails in study of 163,000 DOAC users
- Author:
- Bruce Jancin
Publish date: April 16, 2018